Long-Term Antibody Persistence at 1, 3 and 5 Years After a Fourth Dose of GSK Biologicals' Hib-MenCY-TT Vaccine Compared to ActHIB

This study has been completed.

Study NCT00359983 Information provided by GlaxoSmithKline

First Received: July 31, 2006 Last Updated: September 21, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	May 2011
Primary Completion Date:	November 2007 (Final data collection date for primary outcome measure)